Neurotech International (ASX:NTI) Total Current Liabilities : A$0.28 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Neurotech International Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Neurotech International's total current liabilities for the quarter that ended in Dec. 2023 was A$0.28

Neurotech International Total Current Liabilities Historical Data

The historical data trend for Neurotech International's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International Total Current Liabilities Chart

Neurotech International Annual Data

Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23

Total Current Liabilities

Get a 7-Day Free Trial 0.36 0.73 0.35 0.59 1.35

Neurotech International Semi-Annual Data

Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23

Total Current Liabilities Get a 7-Day Free Trial 0.20 0.59 0.37 1.35 0.28

Neurotech International Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Neurotech International's Total Current Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Current Liabilities = Accounts Payable & Accrued Expense + Short-Term Debt & Capital Lease Obligation

= 1.347 + 0

+ Other Current Liabilities + Current Deferred Liabilities

= 0 + 0

= 1.35

Neurotech International's Total Current Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Current Liabilities = Accounts Payable & Accrued Expense + Short-Term Debt & Capital Lease Obligation

= 0.276 + 0

+ Other Current Liabilities + Current Deferred Liabilities

= 0 + 0

= 0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Neurotech International Total Current Liabilities Related Terms
Thank you for viewing the detailed overview of Neurotech International's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurotech International (ASX:NTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » Total Current Liabilities

Comparable Companies

ASX:UBI ASX:SOM ASX:EYE ASX:RSH ASX:MX1 ASX:CMP ASX:CSX ASX:COV ASX:CDX ASX:CVB ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA

Traded in Other Exchanges

N/A

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.neurotechinternational.com

Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

How to Capitalize on the Bakken Oil Boom
By Vitaliy Katsenelson Vitaliy Katsenelson • 11-09-2013

13 Stocks With Dividend Yields Over 10%
By Dividend Dividend • 11-12-2014

18 Stocks with Very High Yields (More Than 10%) and Earnings Growth
By Dividend Dividend • 12-20-2012

9 Stocks with Double-Digit Yields and Buy or Better Recommendations
By Dividend Dividend • 07-17-2013

20 Stocks with Yields over 10% and Highest Buy Ratings
By Dividend Dividend • 01-17-2013

4 Most Recommended Stocks with Double-Digit Yields and Great Earnings Growth
By Dividend Dividend • 06-25-2013

9 Stocks With Yields Over 10% And Buy Or Better Rating
By Dividend Dividend • 08-17-2013

Neurotech International Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Current Liabilities	Get a 7-Day Free Trial										0.20	0.59	0.37	1.35	0.28

Total Current Liabilities	=	Accounts Payable & Accrued Expense	+	Short-Term Debt & Capital Lease Obligation
	=	1.347	+	0
	+	Other Current Liabilities	+	Current Deferred Liabilities
	=	0	+	0
	=	1.35